Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$560.81M
Total Bought:
$167.55M
Total Sold:
$93.95M
Net Transaction:
+$73.60M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Scholar Rock Holding Corporation(SRRK)5,612,8965,612,8960$242.59M$180.45M32.18%-$62.13M
Kalaris Therapeutics, Inc.(KLRS)011,448,081+11,448,081$0$91.93M16.39%+$91.93M
Mineralys Therapeutics, Inc.(MLYS)5,074,9165,674,916+600,000$62.47M$90.12M16.07%+$27.65M
Neurogene Inc.(NGNE)1,717,1271,717,1270$39.25M$20.11M3.59%-$19.15M
Alumis Inc3,266,4983,266,4980$25.67M$20.06M3.58%-$5.62M
Palvella Therapeutics, Inc.(PVLA)679,486679,4860$8.15M$19.02M3.39%+$10.86M
Septerna, Inc.(SEPN)2,768,5203,149,128+380,608$63.40M$18.23M3.25%-$45.17M
Cargo Therapeutics Inc4,415,6894,415,6890$63.67M$17.97M3.20%-$45.70M
LENZ Therapeutics, Inc.(LENZ)986,981526,390-460,591$28.49M$13.53M2.41%-$14.96M
Upstream Bio, Inc.(UPB)2,217,1462,067,146-150,000$36.45M$12.65M2.26%-$23.80M
Arcellx Inc
COMMON STOCK
253,641135,276-118,365$19.45M$8.87M1.58%-$10.58M
Zymeworks Inc.(ZYME)1,000,000666,667-333,333$14.64M$7.94M1.42%-$6.70M
Avadel Pharmaceuticals Plc967,527967,5270$10.17M$7.58M1.35%-$2.59M
Rhythm Pharmaceuticals, Inc.(RYTM)172,647138,118-34,529$9.66M$7.32M1.30%-$2.35M
Nkarta, Inc.(NKTX)3,768,0353,768,0350$9.38M$6.93M1.24%-$2.45M
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$5.55M$6.74M1.20%+$1.20M
Acelyrin Inc2,523,0222,523,0220$7.92M$6.23M1.11%-$1.69M
Contineum Therapeutics, Inc.CL A(CTNM)588,816588,8160$8.63M$4.11M0.73%-$4.52M
vTv Therapeutics Inc.CL A(VTVT)206,784206,7840$2.86M$3.58M0.64%+$726.1K
OnKure Therapeutics, Inc.CL A(OKUR)824,155824,1550$7.09M$3.54M0.63%-$3.54M
Surrozen, Inc.(SRZN)0241,400+241,400$0$2.81M0.50%+$2.81M
ABIVAX Société AnonymeADS(ABVX)850,000425,000-425,000$6.22M$2.66M0.47%-$3.57M
Sutro Biopharma, Inc.(STRO)2,196,8142,196,8140$4.04M$1.43M0.25%-$2.61M
Inozyme Pharma Inc1,562,5001,562,5000$4.33M$1.42M0.25%-$2.91M
Artiva Biotherapeutics, Inc.(ARTV)291,666291,6660$2.94M$875.0K0.16%-$2.06M
Tango Therapeutics, Inc.(TNGX)630,000630,0000$1.95M$863.1K0.15%-$1.08M
Prime Medicine, Inc.(PRME)405,228405,2280$1.18M$806.4K0.14%-$376.9K
Cypherpunk Technologies Inc.(CYPH)2,442,3522,442,3520$7.02M$745.2K0.13%-$6.28M
Hillevax Inc399,637399,6370$827.2K$579.5K0.10%-$247.8K
Terns Pharmaceuticals Inc202,348202,3480$1.12M$558.5K0.10%-$562.5K
Bolt Biotherapeutics Inc1,049,1531,049,1530$561.4K$419.7K0.07%-$141.7K
Curis, Inc.(CRIS)198,216185,943-12,273$606.5K$390.5K0.07%-$216.1K
Lyra Therapeutics Inc1,965,6891,390,130-575,559$405.7K$175.6K0.03%-$230.1K
Kronos Bio Inc78,13178,1310$74.2K$64.5K0.01%-$9.8K
Nuvation Bio Inc.W EXP 02 10 202(NUVB)133,333133,3330$30.7K$42.7K0.01%+$12.0K
Allakos Inc172,089172,0890$208.2K$39.2K0.01%-$169.1K
Surrozen, Inc.W EXP 08 01 203(SRZN)99,99999,9990$2.1K$3.0K0.00%+$860
Aclaris Therapeutics, Inc.(ACRS)2,385,0600-2,385,060$5.91M$0—-$5.91M
Allovir Inc82,3360-82,336$34.6K$0—-$34.6K
Climb Bio, Inc.(CLYM)2,609,1140-2,609,114$4.70M$0—-$4.70M
Day One Biopharmaceuticals I
COM
147,3190-147,319$1.87M$0—-$1.87M
Immatics N.V.SHS(IMTX)198,0000-198,000$1.41M$0—-$1.41M
Janux Therapeutics, Inc.(JANX)11,2630-11,263$603.0K$0—-$603.0K
Jasper Therapeutics, Inc.(JSPR)584,6420-584,642$12.50M$0—-$12.50M
Verona Pharma PlcADS97,6250-97,625$4.53M$0—-$4.53M
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q1 2025 | TickerTrail